1. Clinical Overview
A fixed-dose topical combination of a potent corticosteroid (Betamethasone) and an antimicrobial/antifungal agent (Clioquinol). Betamethasone provides potent anti-inflammatory, anti-pruritic, and vasoconstrictive effects, while Clioquinol acts against a broad spectrum of dermatophytes, yeasts (including Candida), and certain bacteria (Gram-positive and Gram-negative). This combination is specifically indicated for inflammatory dermatoses complicated or at high risk of secondary bacterial or fungal infections.
| Onset | Duration | Bioavailability |
|---|---|---|
| Anti-pruritic effect may be noticed within a few hours. Anti-inflammatory effects typically begin within 24-48 hours. | Topical corticosteroid effects can persist for several hours to days after application, depending on the condition and skin site. | Topical bioavailability is variable and depends on skin integrity, site, and occlusion. Systemic absorption of Betamethasone is generally low (<5%) from intact skin but increases significantly with damaged skin, large surface area, prolonged use, or occlusive dressings. Clioquinol has minimal systemic absorption (<1%). |
2. Mechanism of Action
Betamethasone binds to cytoplasmic glucocorticoid receptors, modulating gene transcription. This leads to synthesis of anti-inflammatory proteins (lipocortin) and inhibition of pro-inflammatory mediators (cytokines, leukotrienes, prostaglandins). It also causes vasoconstriction. Clioquinol acts by chelating essential metal ions (e.g., Fe, Cu) required for microbial enzyme function, disrupting mitochondrial respiration and DNA synthesis in fungi and bacteria.
3. Indications & Uses
- Inflammatory dermatoses with secondary or suspected bacterial/fungal infections: Eczema (atopic, nummular, stasis), Dermatitis (contact, seborrheic, exfoliative)
- Infected intertrigo (Candidal or bacterial)
- Tinea corporis/cruris/pedis with significant inflammation
- Psoriasis (plaque type) with risk of infection
4. Dosage & Administration
Adult Dosage: Apply a thin film to the affected area 2 to 3 times daily. Rub gently until it disappears. Duration should be limited, typically 1-2 weeks for acute conditions. Do not exceed 4 weeks without medical supervision.
Administration: Wash and dry the affected area thoroughly before application. Use fingertips to apply a thin layer. Wash hands after application unless hands are being treated. Do not bandage or cover the area unless directed by a physician (occlusion dramatically increases absorption and side effects). Do not use on broken skin or open wounds extensively.
5. Side Effects
Common side effects may include:
- Local burning or stinging sensation (especially on broken skin)
- Itching
- Dryness of skin
- Erythema
- Folliculitis
- Skin irritation
- Hypopigmentation or hyperpigmentation at application site
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Topical Corticosteroids | Additive risk of local and systemic side effects. | Major |
| Topical Retinoids (Tretinoin, Adapalene) | May increase skin irritation and dryness. | Moderate |
| Topical Astringents, Alcohol-based preparations | May increase stinging, burning, and dryness. | Moderate |
| Systemic Corticosteroids (e.g., Prednisolone) | Increased risk of systemic corticosteroid side effects and HPA axis suppression. | Major |
7. Patient Counselling
- DO use exactly as directed by your doctor.
- DO wash and dry the area before application.
- DO use a thin film; more is not better.
- DO wash your hands after applying, unless treating hands.
- DON'T use it for longer than prescribed.
- DON'T apply to the face, groin, or armpits unless specifically told to do so.
- DON'T cover the area with tight bandages or plastic wraps unless advised.
- DON'T use it for conditions it was not prescribed for.
- DON'T let the tube tip touch the skin to avoid contamination.
8. Toxicology & Storage
Overdose: Topical overdose manifests as severe local side effects: pronounced skin atrophy, striae, telangiectasia, ulceration, and signs of systemic corticosteroid absorption (hyperglycemia, fluid retention, hypertension, Cushingoid features, HPA axis suppression). Chronic excessive use of Clioquinol could theoretically lead to iodism.
Storage: Store at room temperature (15-25°C), protected from light and moisture. Do not freeze. Keep the tube tightly closed. Keep out of reach and sight of children. Do not use after the expiry date printed on the pack.